More misery for the amyloid hypothesis

More misery for the amyloid hypothesis

Further to our feature, a few weeks ago, on the state of health of the amyloid hypothesis – the dominant hypothesis to explain Alzheimer’s disease – comes news of yet another abandoned trial. This time the company is Merck and the drug under test is...
ISEMPH 2017 Meeting Poster

ISEMPH 2017 Meeting Poster

Download 8.5×11 poster                   Download A4 poster Learn more about the meeting and download a printable poster, here. Share this:TwitterFacebookEmailPrintWhatsAppLinkedInLike this:Like...
Hot Topic: Alzheimer’s Disease

Hot Topic: Alzheimer’s Disease

Four essays address the Hot Topic of Alzheimer’s Disease. Please contribute your comments at the end of each essay, or send your own essay to [email protected]. After solanezumab – where does Alzheimer’s disease research go from here?  Jeremy Taylor...